Omthera Pharmaceuticals prices upsized IPO below the range at $8

By
A A A

Omthera Pharmaceuticals, which has developed a prescription fish oil capsule that reduces triglyceride levels, raised $64 million by offering 8.0 million shares at $8, well below the range of $12 to $14. Omthera, which initially filed confidentially on 1/25/2013, plans to list on the NASDAQ under the symbol OMTH. BofA Merrill Lynch, Barclays and Leerink Swann acted as lead managers on the deal.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , IPOs

Referenced Stocks: OMTH

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Budgeting for Baby
Budgeting for Baby                  
A Home to Retire In
A Home to Retire In                 

Stocks

Referenced

Most Active by Volume

29,406,025
  • $16.987 ▼ 0.37%
24,008,021
  • $13.66 ▼ 3.74%
22,638,763
  • $76.83 ▼ 2.80%
22,254,029
  • $14.715 ▼ 0.51%
21,669,357
  • $98.029 ▼ 0.77%
17,350,393
    $16.90 unch
16,810,214
  • $40.735 ▼ 0.04%
16,762,719
  • $100.18 ▼ 0.57%
As of 10/1/2014, 11:10 AM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com